Prison therapeutic community no better than counseling. by unknown
Send email for updates
 About updates
Key points
From summary and commentary
In a US prison for problem drug users nearly all
new arrivals joined a study which for the first
time in a prison setting rigorously compared
intensive residential therapeutic community
treatment to outpatient counselling.
Over a three-year post-release follow-up period
no extra reduction in reimprisonment was found
from the intensive option.
The same finding emerged among prisoners at
the highest risk of re-offending, confounding
expectations that the more intensive treatment
would be particularly suitable for these offenders.
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For the first time in a prison setting a randomised trial rigorously compared intensive residential therapeutic
community treatment to outpatient counselling. Confounding expectations, the US prison for problem drug
users which hosted the study gained nothing in terms of preventing recidivism by allocating even high-risk
prisoners to the more intensive treatment.
SUMMARY In a rare randomised trial, the featured analysis attempted not just to establish the effectiveness
of a US prison therapeutic community relative to outpatient treatment, but also what types of inmates may
differentially benefit from these modalities.
Background
In the USA, prison-based therapeutic community treatment
has become a dominant, evidence-based paradigm for
treating drug-dependent inmates. These facilities are
present in over a quarter of prisons and serve an estimated
45,486 offenders. Therapeutic communities are residential,
communal living centres designed to treat the whole person
through the use of the peer community. Residents typically
progress through several treatment phases which grant
them increasing levels of responsibility. Treatment activities
include morning meetings, individual and group therapy,
lifeskills groups, and participation in a therapeutic milieu
with well-specified roles, privileges, and responsibilities.
Community norms are emphasised and reinforced with clear
rewards and sanctions intended to develop self-control and
responsibility.
Syntheses of evaluations of prison-based drug treatment have generally shown therapeutic communities are
associated with the strongest and most consistent reductions in rates of relapse to drug use and criminal
recidivism. In 2006 a rigorous analysis found prison-based therapeutic communities were associated with
reduced rates of reimprisonment and re-arrest, but reduced rates of relapse to drug use only when mandatory
aftercare was also provided. However, only two of the 30 therapeutic community studies (1 2) had effectively
allocated patients at random to these facilities versus an alternative approach, helping to ensure that
differences in outcomes were not due to differences in the patients. Across these two studies there was a
significant reduction in criminal recidivism but not in relapse to drug use. Only one of the two studies was fully
randomised. Even in that study, participants had volunteered for treatment, raising concerns about
generalisability to the entire potential caseload.
Less intensive alternatives to prison therapeutic communities include outpatient substance use counselling
programmes typically offered to moderate-risk inmates. In contrast to therapeutic communities, outpatients
are not immersed in their programmes, which are integrated into other daily activities such as work,
education, and recreation, and typically they do not live together in a segregated unit dedicated to treatment.
Outpatient programmes also typically provide fewer hours of treatment over a shorter time span.
This raises the issue of who benefits most from different types of programmes. In the criminal justice system,
a well-evidenced system for determining this is the risk-need-responsivity framework:
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Risk refers to the likelihood that an inmate will re-offend upon release. All things being equal,
treatment should be targeted toward higher risk inmates.
Need refers to dynamic factors contributing to criminal propensity which can be changed through
treatment. Criminogenic needs include antisocial peers, antisocial ways of thinking, substance use, and
circumstances in the domains of family, work, and leisure. Effective interventions target these needs.
Responsivity factors include characteristics of the services delivered (general) and attributes of the
individual offender (specific) that can interact to modify the impact of treatment. General responsivity
includes treatment modality, intensity, and duration. Specific responsivity includes the offender’s
motivation, gender, race/ethnicity, level of cognitive functioning, and psychological attributes including
negative feelings and emotions and the ‘constraint’ they exercise over impulsive tendencies to engage
in risk-taking or sensation-seeking while rejecting conventional norms and disregarding the feelings or
rights of others.
The framework highlights the need for ongoing assessment of both the offender’s state of mind and of
the services provided to identify ways to improve response to these services.
Featured study aims and methods
Against this background, the featured study tested four hypotheses:
1 First and foremost, based on previous research it was expected that the prison therapeutic
community would result in lower rates of reimprisonment than outpatient treatment.
2 Second, based on the risk-need-responsivity framework, higher risk inmates were expected do better
in the more intensive option – the therapeutic community.
3 Third, based on the framework’s principle of specific responsivity and other research, it was expected
that more depressed and hostile (‘negative affect’) inmates would do worse in either type of treatment.
4 Finally, it was expected that previously unexamined interactions between treatment modality
(therapeutic community v. outpatient) and specific responsivity characteristics of the offender (such as
negative affect and their risk of re-offending) would affect reimprisonment rates. With no prior
research as a guide to exactly what might be found, nevertheless it was hypothesised that inmates with
relatively high levels of negative affect and low levels of risk would have worse outcomes in the more
intensive therapeutic community treatment.
Setting for the study was the Chester men’s prison in Pennsylvania in the USA, a facility dedicated to
problem drug users. To be admitted, offenders had to have severe drug-related problems approximating
to dependence, 18–34 months left to serve, and no serious mental health problems. These rules meant
all the inmates met at least minimum eligibility criteria for therapeutic community treatment. Such
treatment was provided at the prison in the form of an intensive, 12-month programme intended for
high-need inmates. Before the study an evaluation established that the programme satisfactorily
implemented the prison-based therapeutic community model, and it was also formally accredited as
meeting the relevant standards. A 12-month outpatient programme catered for inmates requiring less
intensive (150 hours v. 1,300 in the therapeutic community) treatment. Graduates of both programmes
were required to complete a six-month community aftercare programme.
All inmates admitted to Chester during the 15-month recruitment period were asked to join the study.
Of the 831, 790 or 95% agreed. Later 59 were excluded because their needs were considered to
require allocation to the therapeutic community, leaving 731 randomly allocated to this modality or to
outpatient counselling. Logistic issues and missing data reduced the sample whose results could be
analysed to 604 men – 286 allocated to the therapeutic community and 318 to outpatient treatment.
They averaged 32 to 33 years of age and nearly two-thirds were African American. Their current and
former offences were rated as fairly but not very severe, and their drug use problems as roughly
equating to a diagnosis of dependence. Asked which drugs had caused them the most serious problems
before being imprisoned, about a fifth each specified alcohol, cannabis or cocaine/crack, and 11%
opiates.
Based on Pennsylvania state records, reimprisonment was the study’s indicator of a return to crime.
Primarily at issue was how the programmes the prisoners were allocated to affected how long after
release from Chester they remained out of prison over a three-year follow-up period.
Main findings
All but 13% of the prisoners completed their treatment programmes, evenly divided across the two
programmes, and 41% were reimprisoned during the three-year follow-up period – 44% allocated to
the therapeutic community versus 38% to the outpatient programme. The details presented below
confirm that overall outcomes were worse among patients allocated to the therapeutic community and
also that compared to outpatient treatment, this was relatively ineffective for offenders at high risk of
offending – both opposite to expectations. Findings on negative emotions were more in line with
expectations of greater benefit from the therapeutic community than outpatient treatment.
First the analysts tested whether across the entire sample and without adjusting for any other factors,
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reimprisonment was significantly more or less likely or delayed following allocation to the
therapeutic community. This was not the case, though the slight tendency was for worse
outcomes among the therapeutic community than the outpatient sample. The results
contradicted hypothesis 1.
Once other factors had been taken into account, this slight tendency became greater and
statistically significant, yet more sharply contradicting hypothesis 1. Among the other factors
was whether the prisoner had failed to complete either of the treatment programmes, events
very strongly related to post-release return or more rapid return to prison. Also related in the
same direction were the offender’s risk of reoffending as assessed at the start of treatment, and
the seriousness of the offence for which they had been imprisoned.
The next step was to take into account the assessments made of the prisoners in the final
month of prison treatment, an attempt to establish whether how well they had responded to
treatment affected their risk of being (more rapidly) reimprisoned. These adjustments left the
same factors related to reimprisonment as before, including the apparently negative effect of
allocation to the therapeutic community. Results were in line with the expectation (hypothesis
3) that prisoners experiencing high levels of negative emotions would more often or more
rapidly be reimprisoned. However, this finding was not statistically significant, so failed to
confirm the hypothesis. Findings were similar with respect to assessments of the offender’s
degree of lack of constraint.
In a final step, the analysts looked for the expected signs that inmates with relatively high
levels of negative affect and low risks of reoffending would have worse outcomes after the more
intensive therapeutic community treatment. For negative affect the results were as expected
(hypothesis 4): particularly hostile or angry prisoners were reimprisoned or reimprisoned more
rapidly if they had been allocated to the therapeutic community. But for risk of reoffending, the
results were opposite to expectations (hypothesis 2). Rather than doing better because they
needed more intensive treatment, high-risk prisoners were also reimprisoned or reimprisoned
more rapidly if they had been allocated to the therapeutic community. In this final step when all
the planned variables and their interactions had been taken into account, still overall the
therapeutic community was no more effective than outpatient counselling.
Another way to present the findings confirmed that, unexpectedly, high-risk patients did best in
the less intensive programme. The method was to divide the samples into two sets of three: for
each of negative emotions and reoffending risk, the bottom and top quarters and the middle
halves. Based on simply the risk of reimprisonment at all during the three years (not its
rapidity), as expected offenders low in negative emotions did best in the therapeutic community,
and the remainder did best in outpatient treatment. Turning to the risk of reoffending, at low
and medium levels of risk, reimprisonment rates after therapeutic community and outpatient
programmes were virtually identical, but at high levels the outpatient programme was
preferable. (The charts below show these figures transformed from the source so that a higher
% equates to a better outcome in the form of not being recorded as having been reimprisoned.)
The authors’ conclusions
Four features distinguished the current study from most of its predecessors: evidence that the
therapeutic community programme had been well implemented; a large enough sample to
simultaneously analyse the interacting influences of several variables; a true randomised
controlled trial methodology; and examination of interactions between treatment modality and
the characteristics of individual offenders.
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Results of this unique
trial may warrant a
rethink of official US
and UK guidance
Results failed to demonstrate the predicted superiority of a prison therapeutic
community over less intensive outpatient counselling, and failed to support risk-need-
responsivity predictions that inmates at higher risk of reoffending would do better in the
therapeutic community. Perhaps the most intensive intervention is not always the most
effective (or appropriate) for those with the highest level of reoffending risk. Other
factors are also important, especially for interventions such as therapeutic communities
which entail intensive interaction and confrontation, and may mean such interventions
are not appropriate for all high-risk inmates. Responsivity factors such as negative
affect, cognitive limitations, interpersonal skills, prior treatment history, may dictate
something other than an intensive therapeutic community programme for a particular
high-risk prisoner at a particular time.
Therapeutic community participants who were high in reoffending risk and negative
affect had significantly higher reimprisonment rates than their counterparts in outpatient
treatment. Such inmates may be poor candidates for a prison therapeutic community
and do better in less intensive regimens.
The findings suggest several important considerations for understanding the risk-need-
responsivity framework. While this emphasises the importance of assessing reoffending
risk level and needs of individual offenders, ideally these assessments must be ongoing
in order to track change through treatment. All too often, assessment is done only at
intake to the programme or the prison. Inattention to ongoing reassessment may help to
explain the findings of the featured study. Designating a group of inmates as high risk
and placing them together in a fixed-intensity and fixed-duration therapeutic community
(or any other programme) may not be an optimal strategy. Another key implication is
the cost-effectiveness of non-residential compared to residential drug treatment in
prison. Estimates suggest that the average cost for residential drug treatment is nearly
three times the cost of non-residential treatment.
 COMMENTARY A truly landmark trial, this seems only the second
randomised trial of a prison-based therapeutic community and the first to make a crucial
comparison – not between substance use treatment and no specific treatment at all, but
between two prominent but very different in-prison treatment modalities. While it may
be generally accepted that some treatment should be offered to substance-dependent
inmates, what that treatment should be is an open question which has not rigorously
been evaluated. At least in the context of the US prison which hosted the featured study,
making arrangements to house problem drug users in a separate unit and offering
intensive therapy gained no respite in the burden imposed on the state by having to
reimprison offenders. Most significant is that even prisoners assessed before treatment
as at particularly high risk of reoffending did not respond better to more intensive and
segregated treatment. It remained, however, an open question whether the therapeutic
community was best for those at high risk of reoffending specifically because they were
very severely dependent on drugs or alcohol.
Published well before this trial, in 2005 US government guidance portrayed therapeutic
communities as “among the most successful in-prison treatment programs”, whose
intensity makes them “preferable for the placement of offenders who are assessed as
substance dependent”. Also well before the trial, when in 2006 the UK Department of
Health published guidance on the clinical management of drug dependence in prisons, it
envisaged the “principal elements” to include “Progression, through CARAT case
management, to other Tier 3 and 4 services in prisons, such as rehabilitation
programmes and therapeutic communities.”
How many UK prisons host therapeutic communities
for problem drug users seems not to be centrally
collated, but certainly they exist. Though not
necessarily hierarchically structured like a
therapeutic community, also found in UK prisons are
‘drug recovery wings’ where problem drug users are
segregated in a more securely drug-free unit focused
on recovery from addiction and offering a structured rehabilitation programme bolstered
by peer support and role-modelling.
Results of the featured study beg the question of whether such arrangements are really
more effective than non-segregated and non-intensive treatment, and in turn, whether
this unique randomised trial is enough to warrant a rethink of official guidance in Britain
and in the USA.
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A landmark trial
Apart from its subject, among the features which make the featured study a landmark
trial are those which bolster confidence in the findings. Near universal participation by
the potential caseload eliminates questions about whether (self-)selection of prisoners
for the trial biased outcomes. Given the containing prison context, nearly all participants
could safely be allocated to outpatient treatment; outside prison, whittling the sample
down to those assessed as being able to manage outside a residential setting robs those
settings of what is thought a distinctive asset – being able to cater for the most severe
cases. Use of official imprisonment records eliminated the need to recontact participants,
a process which often means many are lost to the analysis. Imprisonment in the same
US state is an imperfect indicator of a return to crime, but there is no reason to believe
those imperfections would bias outcomes – and for a prison system trying to decide
whether it is cost-beneficial to mount more intensive treatment, arguably this is a key
measure.
Given an unprecedentedly well-levelled playing field allied with completeness of
sampling and data, it is all the more significant that no reimprisonment (presumed
indicative of reoffending) advantage was gained from the more intensive and probably
more expensive therapeutic community programme. Not only were expectations of
greater success from the therapeutic community confounded, but so too were
expectations of greater success specifically among offenders with the strongest
criminogenic characteristics. However, none of the criteria on which this was judged
related to the severity of the substance use problems targeted by the treatments. The
study does not seem to have tested whether greater severity on the one measure of
pre-treatment drug problems helped identify prisoners more suitable for therapeutic
community treatment.
In the community’s favour was that prisoners who by the end of treatment were
relatively low in anger and hostility had on average responded better to the therapeutic
community than to outpatient counselling. Without pre-treatment measures, we cannot
know whether this means it is best (all else being equal) to allocate prisoners who start
this way to a therapeutic community, or whether the inmates who ended up relatively
calm after 12 months of intensive therapy and intensively interacting with staff and
other residents were those who adjusted best to this more challenging regimen.
The authors of the featured study suggested their results have important implications
for cost-effectiveness; they found therapeutic community treatment no more effective,
yet residential care of this kind has been estimated to cost nearly three times as much
as non-residential. However, accommodation and associated costs form a large part of
the extra expense, and in prison, these are provided for both therapeutic community
and non-residential patients. An update to the estimates published in 2008 calculated
costs for prison therapeutic communities additional to those arising simply from
imprisonment. On this basis, an episode of treatment in a prison community typically
cost $1536 compared to $21,251 outside prison, and about the same as an episode of
counselling or other drug-free non-residential treatments outside prison. How much
in-prison counselling might cost was not estimated, but the gap between this and
therapeutic community treatment will not be as great as outside prison.
Other trials
No other randomised trial has made the same comparison as the featured trial, but
other US trials which approached the ideal of randomisation have compared prison
therapeutic community outcomes against no specific substance use treatment – or none
identified in the reports on the studies.
Most rigorous was the evaluation of the Amity therapeutic community at Donovan prison
in California in the early 1990s, a study previously analysed for the Effectiveness Bank.
Unlike the featured study, only prisoners randomly allocated to the Amity in-prison
therapeutic community (and then only those who successfully completed the
programme) could avail themselves of the offer of another six to 12 months in a similar
residential regimen after release from prison. Many did, and it seemed that the extra
numbers who continued treatment after release and the extra months in treatment
accounted for Amity residents’ slightly lower risk of reimprisonment over a five-year
post-release follow-up. During this time, 76% of former Amity residents had been
reimprisoned compared to 83% who had not entered the unit, and on average they had
stayed out of prison for six months longer.
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Our fully referenced commentary on the Amity study suggested that the findings were
in line with findings generally that in-prison treatment has only a minor or no impact on
recidivism unless followed by further treatment on release. US evidence on the role of
post-release aftercare and continuing supervision in reducing recidivism and drug use is
much stronger than for prison treatment itself, in the USA generally conducted on
therapeutic community lines. Even on its own with no preceding prison programme,
post-prison rehabilitation has been found to have exerted a greater positive effect than
prison treatment.
That latter finding derived from an evaluation of the US state of Delaware’s KEY/CREST
programme. Delaware’s prison system eased inmates back into the community via a
work-release programme which prepared them for employment and towards the end of
which they were expected to be working. For problem drug users this was integrated
with therapeutic community treatment, but when slots in this facility were unavailable,
otherwise eligible prisoners were diverted to the state’s routine work-release
programme. There were exceptions, including prisoners who had completed treatment in
an in-prison therapeutic community, who were prioritised for continuing treatment in
the work-release community. Compared to work-release on its own, when integrated
with a therapeutic community the regimen was associated over the five years after
release with fewer participants being re-arrested for a new offence, and among those
who could be re-assessed, more no longer using illegal drugs. However, the in-prison
therapeutic community on its own did not improve long-term outcomes – the reason
why the transitional work-release arrangements were introduced.
The 2006 review cited by the featured report was updated in 2012. Five more studies
were found but still only two which had randomly assigned participants to a therapeutic
community versus minimal or no treatment. The findings indicated that therapeutic
community treatment helped prevent a return to crime and probably also to drug use,
and that mandating aftercare improved outcomes. But with so few rigorous studies, the
results could result from an accumulation of bias. Unlike the featured study, the analysis
did not address the issue of whether prisons should prioritise therapeutic communities
over other treatment modalities.
Published in 2010 another review focused on US prison therapeutic communities.
Confirming the importance of follow-on care after prison, overall it concluded that
“Positive results have generally been found at 12, 24, 36, and 60 months, but
differences between the treatment and comparison groups tend to converge at 36
months except for the groups that have aftercare.” Apart from the Amity and
KEY/CREST evaluations described above, it spotlighted the ‘Stay ’n Out’ study (1 2) as
one where inmates “were randomly assigned to the [therapeutic community] or control
groups”. In fact, the no-treatment control groups consisted of prisoners who had
volunteered for the therapeutic community but having been placed on a waiting list,
were not admitted “because they did not meet the time eligibility criterion – an inmate
can be no more than 12 months and no less than seven months away from parole
eligibility”. The thinking was that these prisoners were equally motivated but
presumably for reasons unrelated to their later recidivism, could not start treatment.
However, this assumption is not necessarily valid. Rather than allocating prisoners on a
random or first come, first served basis, prison authorities can be expected to exercise
judgement over who should be prioritised for a scarce resource.
Among the men in the Stay ’n Out study, significantly more no-treatment than
therapeutic community prisoners were re-arrested while on parole (41% v. 27%), but
the former had over six months or 19% longer to be arrested, and if they were
arrested, this tended to be more delayed than among the therapeutic community
prisoners. Successful completion of the parole period – considered indicative of the “the
long-term effects of treatment” – was no more common after therapeutic community
treatment than after no treatment at all. Other comparison groups had been offered
counselling or less structured residential therapy, but not in the prison which hosted the
therapeutic community, making the comparison between these treatments vulnerable to
bias. As with the no-treatment comparison, arrests were proportionately fewer among
therapeutic community prisoners than among those allocated to alternative treatment,
but successful parole completion was not significantly more likely. A parallel study
concerned female inmates, but with so few participants the results were a less reliable
indicator of relative success rates.
Thanks for their comments on this entry in draft to research author Wayne Welsh of Temple University in
Philadelphia in the USA. Commentators bear no responsibility for the text including the interpretations and
any remaining errors.
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